<DOC>
	<DOCNO>NCT02264041</DOCNO>
	<brief_summary>Study investigate effect cytochrome P 450 3A4 inhibition itraconazole single dose pharmacokinetics cilobradine</brief_summary>
	<brief_title>Effect Cytochrome P 450 3A4 Inhibition Itraconazole Single Oral Dose Pharmacokinetics Cilobradine</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>1 . Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test 1.1 No find deviate normal clinical relevance 1.2 No evidence clinically relevant concomitant disease 2 . Age ≥21 Age ≤55 year 3 . BMI ≥18.5 BMI &lt; 30 kg/m2 ( Body Mass Index ) 4 . Resting pulse rate ( PR ; 10 min . supine position ) 55 bpm 5 . Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological , ophthalmological , hormonal disorder 2 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 3 . History relevant orthostatic hypotension , faint spell blackout . 4 . Chronic relevant acute infection 5 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 6 . Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial 7 . Use drug might reasonably influence result trial base knowledge time protocol preparation within 10 day prior administration trial . 8 . Participation another trial investigational drug within two month prior administration trial 9 . Smoker ( 10 cigarette 3 cigar 3 pipes/day ) 10 . Inability refrain smoke trial day 11 . Alcohol abuse ( 60 g/day ) 12 . Drug abuse 13 . Blood donation ( 100 mL within four week prior administration trial ) 14 . Excessive physical activity ( within one week prior administration trial ) 15 . Any laboratory value outside reference range clinical relevance</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>